|Australian Pharmaceutical Industries Limited -- Australia Stock|| |
AUD 1.53 0.01 0.65%
Chief Legal Counsel, Company Secretary
Mr. Peter F. Sanguinetti serves as General Counsel, Company Secretary of Australian Pharmaceutical Industries Ltd., since November 2007. Mr Sanguinetti BJuris, LLB, GAICD has extensive experience and was previously Company Secretary and General Counsel of Kodak Pty Ltd for 9 years, responsible for legal and company secretarial activities for the Kodak group across Asia. Mr Sanguinetti was also a nonexecutive director of HPAL Limited from January 2005 to November 2007. On 2 June 2009.
Executive Since 2007
(61) 3 8855 3401 www.api.net.au
The company has return on total asset (ROA)
of 3.85 %
which means that it generated profit of $3.85 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE)
of 9.6 %
meaning that it generated $9.6 on every $100 dollars invested by stockholders.
The company has accumulated 32.6 M in total debt with debt to equity ratio (D/E) of 5.8 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Australian Pharmaceutical Industries Limited has Current Ratio of 1.29 suggesting that it is in a questionable position to pay out its financial obligations in time and when they become due.
Australian Pharmaceutical Industries Limited primarily engages in the wholesale distribution of pharmaceutical, medical, health, beauty, and lifestyle solutions to pharmacies. Australian Pharmaceutical Industries Limited (API) is traded on Australian Securities Exchange in Australia. It is located in Level 5, 250 Camberwell Road, Camberwall, Victoria 3124, Australia and employs 18 people.